financetom
Business
financetom
/
Business
/
Bath & Body Works appoints former Nike executive Daniel Heaf as CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bath & Body Works appoints former Nike executive Daniel Heaf as CEO
May 26, 2025 10:15 AM

May 19 (Reuters) - Bath & Body Works ( BBWI ) said on

Monday it has appointed former Nike chief strategy and

transformation officer, Daniel Heaf, as chief executive,

effective immediately.

He replaces Gina Boswell, who has been at the helm of the

beauty and skincare firm since November 2022. In March, the

company said Boswell would be temporarily absent, for several

weeks, for surgery.

The change in leadership comes as the company grapples with

uncertain discretionary spending, which caused it to forecast

annual sales and profit largely below expectations in February.

The company on Monday also announced preliminary

first-quarter results and said it maintains its full-year net

sales and profit forecast.

Net sales rose 3% to $1.42 billion for the quarter ended May

3, in line with analysts' expectations, while profit per share

of 49 cents exceeded estimates of 42 cents, according to data

compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Nov 13, 2025
03:54 AM EST, 11/13/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on November 10, 2025, sold 89,265 shares in Adaptive Biotechnologies ( ADPT ) for $1,315,180. Following the Form 4 filing with the SEC, Robins has control over a total of 2,869,975 common shares of the company, with 2,869,975 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178064925000002/xslF345X05/primary_doc.xml...
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Nov 13, 2025
03:55 AM EST, 11/13/2025 (MT Newswires) -- Ryan S. Keeton, Chief Brand Officer, on November 10, 2025, sold 10,000 shares in Carvana ( CVNA ) for $3,250,300. Following the Form 4 filing with the SEC, Keeton has control over a total of 104,958 Class A common shares of the company, with 104,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1690820/000170054225000011/xslF345X05/wk-form4_1762991500.xml ...
Freshworks Insider Bought Shares Worth $1,994,166, According to a Recent SEC Filing
Freshworks Insider Bought Shares Worth $1,994,166, According to a Recent SEC Filing
Nov 13, 2025
03:53 AM EST, 11/13/2025 (MT Newswires) -- Tyler Sloat, Chief Financial & Operating Officer, on November 11, 2025, executed a purchase for 171,615 shares in Freshworks ( FRSH ) for $1,994,166. Following the Form 4 filing with the SEC, Sloat has control over a total of 1,149,244 Class A common shares of the company, with 1,149,244 shares held directly. SEC...
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Nov 13, 2025
03:56 AM EST, 11/13/2025 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on November 10, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,167,930. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000054/xslF345X05/wk-form4_1762991674.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved